Skip to main content
Top
Published in: Rheumatology International 1/2012

01-01-2012 | Original Article

Elevated interleukin-18 and skewed Th1:Th2 immune response in lupus nephritis

Authors: Xiaoqian Liu, Chunde Bao, Dawei Hu

Published in: Rheumatology International | Issue 1/2012

Login to get access

Abstract

There is evidence that interleukin-18 plays a role in lupus nephritis (LN). Since interleukin -18 (IL-18) promotes polarization of the immune response toward Th1, we investigated level of IL-18 and assessed the phenotypic distribution of Th1 and Th2 type cells in LN. A predominance of Th1 type (IFN-γ+) cells and significant correlations with serum IL-18 was seen in the patients with LN compared to healthy controls. Although most patients were treated with high dosage of glucocorticoid and other immunosuppressive agents, higher level of IL-18 was found in both serum and glomeruli. However, there was no paralleled upregulation of its gene expression in peripheral blood mononuclear cells. Our findings indicate that the elevated IL-18 should be a symbol of disease activity and play a major role in the pathogenesis of LN by promoting cytokine imbalance towards Th1 type immune response. We conclude that patients with LN would benefit from it while the bioactivity of this cytokine was effectively counteracted.
Literature
1.
go back to reference Kelley VR, Wuthrich RP (1999) Cytokines in the pathogenesis of systemic lupus erythematosus. Semin Nephrol 19:57–66PubMed Kelley VR, Wuthrich RP (1999) Cytokines in the pathogenesis of systemic lupus erythematosus. Semin Nephrol 19:57–66PubMed
2.
go back to reference Tucci M, Calvani N, Richards HB, Quatraro C, Silvestris F (2005) The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. Ann NY Acad Sci 1051:421–432PubMed Tucci M, Calvani N, Richards HB, Quatraro C, Silvestris F (2005) The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. Ann NY Acad Sci 1051:421–432PubMed
3.
go back to reference Wong CK, Ho CY, Li EK, Lam CW (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9(8):589–593PubMed Wong CK, Ho CY, Li EK, Lam CW (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9(8):589–593PubMed
4.
go back to reference Aringer M, Smolen JS (2005) Cytokine expression in lupus kidneys. Lupus 14(1):13–18 ReviewPubMed Aringer M, Smolen JS (2005) Cytokine expression in lupus kidneys. Lupus 14(1):13–18 ReviewPubMed
5.
go back to reference Kaneko H, Ogasawara H, Naito T, Akimoto H, Lee S, Hishikawa T, Sekigawa I, Tokano Y, Takasaki Y, Hirose SI, Hashimoto H (1999) Circulating levels of betachemokines in systemic lupus erythematosus. J Rheumatol 26:568–573PubMed Kaneko H, Ogasawara H, Naito T, Akimoto H, Lee S, Hishikawa T, Sekigawa I, Tokano Y, Takasaki Y, Hirose SI, Hashimoto H (1999) Circulating levels of betachemokines in systemic lupus erythematosus. J Rheumatol 26:568–573PubMed
6.
go back to reference Funauchi M, Ikoma S, Enomoto H, Horiuchi A (1998) Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 27:19–24 Funauchi M, Ikoma S, Enomoto H, Horiuchi A (1998) Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 27:19–24
7.
go back to reference Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, Ohgami E et al (1999) Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 42(8):1644–1648PubMed Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, Ohgami E et al (1999) Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 42(8):1644–1648PubMed
8.
go back to reference Uhm WS, Na K, Song GW, Jung SS, Lee T, Park MH et al (2003) Cytokine balance in kidney tissue from lupus nephritis patients. Rheumatology (Oxford) 42(8):935–938 Uhm WS, Na K, Song GW, Jung SS, Lee T, Park MH et al (2003) Cytokine balance in kidney tissue from lupus nephritis patients. Rheumatology (Oxford) 42(8):935–938
9.
go back to reference Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T et al (2001) Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum 44(9):2097–2106PubMed Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T et al (2001) Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum 44(9):2097–2106PubMed
10.
go back to reference Kikawada E, Lenda DM, Kelley VR (2003) IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFNgamma expression, and diminishes systemic pathology. J Immunol 170(7):3915–3925PubMed Kikawada E, Lenda DM, Kelley VR (2003) IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFNgamma expression, and diminishes systemic pathology. J Immunol 170(7):3915–3925PubMed
11.
12.
go back to reference Dinarello CA (1999) IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103(1 Pt 1):11–24PubMed Dinarello CA (1999) IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103(1 Pt 1):11–24PubMed
13.
go back to reference Amerio P, Frezzolini A, Abeni D, Teofoli P, Girardelli CR, De Pita O et al (2002) Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol 20(4):535–538PubMed Amerio P, Frezzolini A, Abeni D, Teofoli P, Girardelli CR, De Pita O et al (2002) Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol 20(4):535–538PubMed
14.
go back to reference Wong CK, Ho CY, Li EK, Tam LS, Lam CW (2002) Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin Exp Immunol 130(2):345–351PubMed Wong CK, Ho CY, Li EK, Tam LS, Lam CW (2002) Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin Exp Immunol 130(2):345–351PubMed
15.
go back to reference Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A (2002) Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum 46(11):3083–3095PubMed Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A (2002) Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum 46(11):3083–3095PubMed
16.
go back to reference Bossu P, Neumann D, Del Giudice E, Ciaramella A, Gloaguen I, Fantuzzi G et al (2003) IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc Natl Acad Sci USA 100:14181–14186PubMed Bossu P, Neumann D, Del Giudice E, Ciaramella A, Gloaguen I, Fantuzzi G et al (2003) IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc Natl Acad Sci USA 100:14181–14186PubMed
17.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMed
18.
go back to reference Miyaura H, Iwata M (2002) Direct and indirect inhibition of Thl development by progesterone and glucocorticoids. J Immunol 168:l087–l1094 Miyaura H, Iwata M (2002) Direct and indirect inhibition of Thl development by progesterone and glucocorticoids. J Immunol 168:l087–l1094
19.
go back to reference Wozniacka A, Lesiak A, Narbutt J, McCauliffe DP, Sysa-Jedrzejowska A (2006) Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients. Lupus 15(5):268–275PubMed Wozniacka A, Lesiak A, Narbutt J, McCauliffe DP, Sysa-Jedrzejowska A (2006) Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients. Lupus 15(5):268–275PubMed
20.
go back to reference Warchoi T, Lianeri M, Wudarski M, Lacki JK, Jagodzijski PP (2009) IL-18 105 A > C polymorphism contributes to renal manifestations in patients with SLE. Rheumatol Int, April 22 [Epub ahead of print] Warchoi T, Lianeri M, Wudarski M, Lacki JK, Jagodzijski PP (2009) IL-18 105 A > C polymorphism contributes to renal manifestations in patients with SLE. Rheumatol Int, April 22 [Epub ahead of print]
21.
go back to reference Chen DY, Hsieh CW, Chen KS, Chen YM, Lin FJ, Lan JL (2009) Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus 18(1):29–37PubMed Chen DY, Hsieh CW, Chen KS, Chen YM, Lin FJ, Lan JL (2009) Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus 18(1):29–37PubMed
22.
go back to reference Sánchez E, Palomino-Morales RJ, Ortego-Centeno N, Jiménez-Alonso J, González-Gay MA, López-Nevot MA et al (2009) Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. Hum Mol Genet 18(19):3739–3748PubMed Sánchez E, Palomino-Morales RJ, Ortego-Centeno N, Jiménez-Alonso J, González-Gay MA, López-Nevot MA et al (2009) Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. Hum Mol Genet 18(19):3739–3748PubMed
23.
go back to reference Shui HA, Ka SM, Wu WM, Lin YF, Hou YC, Su LC, Chen A (2007) LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis. Rheumatology (Oxford) 46(8):1277–1284 Shui HA, Ka SM, Wu WM, Lin YF, Hou YC, Su LC, Chen A (2007) LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis. Rheumatology (Oxford) 46(8):1277–1284
24.
go back to reference Tucci M, Quatraro C, Lombardi L, Pellegrino C, Dammacco F, Silvestris F (2008) Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum 58(1):251–262PubMed Tucci M, Quatraro C, Lombardi L, Pellegrino C, Dammacco F, Silvestris F (2008) Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum 58(1):251–262PubMed
25.
go back to reference Chen DY, Hsieh TY, Hsieh CW, Lin FJ, Lan JL (2007) Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still’s disease. Arthritis Rheum 57(8):1530–1538PubMed Chen DY, Hsieh TY, Hsieh CW, Lin FJ, Lan JL (2007) Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still’s disease. Arthritis Rheum 57(8):1530–1538PubMed
26.
go back to reference Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Miyawaki S, Amano T, Takeuchi T, Makino H (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still’s disease. Arthritis Rheum 44(3):550–560PubMed Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Miyawaki S, Amano T, Takeuchi T, Makino H (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still’s disease. Arthritis Rheum 44(3):550–560PubMed
27.
go back to reference Faggioni R, Cattley RC, Guo J, Flores S, Brown H, Qi M, Yin S, Hill D, Scully S, Chen C, Brankow D et al (2001) IL-18-binding protein protects against lipopolysaccharide-induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice. J Immunol 167:5913–5920PubMed Faggioni R, Cattley RC, Guo J, Flores S, Brown H, Qi M, Yin S, Hill D, Scully S, Chen C, Brankow D et al (2001) IL-18-binding protein protects against lipopolysaccharide-induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice. J Immunol 167:5913–5920PubMed
28.
go back to reference Zaccone P, Phillips J, Conget I, Cooke A, Nicoletti F (2005) IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin Immunol 115(1):74–79PubMed Zaccone P, Phillips J, Conget I, Cooke A, Nicoletti F (2005) IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin Immunol 115(1):74–79PubMed
Metadata
Title
Elevated interleukin-18 and skewed Th1:Th2 immune response in lupus nephritis
Authors
Xiaoqian Liu
Chunde Bao
Dawei Hu
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1609-9

Other articles of this Issue 1/2012

Rheumatology International 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.